Skip to content
Wenlo
Sign in
← Markets
Market open · Closes 4:00 PM ET

BMY Bristol-Myers Squibb Company

NYSE
$62.65+$0.17 (+0.26%)

As of 12:25:00 PM ET

Loading chart…

Open
$62.43
Previous close
$62.48
Day range
62.17 – 62.85
52-week range
45.27 – 68.64
Volume
302.7K
Avg volume (3M)
11.4M
Market cap
$125.7B
P/E (TTM)
13.54
EPS (TTM)
$4.54
Beta
0.18
Dividend yield
4.03%
Next earnings
—
Ex-dividend
Oct 2, 2026
Sector
Healthcare

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and neuroscience, serving patients with complex and often chronic conditions. Its portfolio includes small-molecule drugs, biologics, and cell therapies, reflecting a broad approach to advanced treatment design and delivery. The company supports healthcare systems through research-driven products used in hospitals, specialty clinics, and outpatient care settings around the world. Bristol-Myers Squibb Company plays an important role in the pharmaceutical market by providing therapies aimed at difficult-to-treat illnesses and by maintaining a diversified pipeline and product mix across multiple disease categories.

BMY news and filings

Loading filings…

Filings from SEC EDGAR.